Key result
Cardiopulmonary bypass is linked to sustained thrombin generation and marked platelet activation during CABG.
Observational
Answers are grounded in this paper and cite their sources.
Demonstrates sustained thrombin and thromboxane activation during cardiopulmonary bypass despite heparin, suggesting persistent clotting and vasoconstrictive risks.
Patients who underwent operations in which cardiopulmonary bypass was used had elevations of plasma fibrinopeptide A which did not return to normal during bypass despite conventional heparin anticoagulation, suggesting inadequate heparin dosage and continued thrombin activity during the operation. Patients who underwent aortocoronary artery grafting had high plasma thromboxane B2 levels and a rapid fall in platelet count at the onset of extracorporeal circulation. Thromboxane elevations were less marked in patients who underwent valve replacement. Platelet aggregation and coronary artery constriction secondary to thromboxane production may contribute to the morbidity of cardiopulmonary bypass.
No takes yet. Share an insight, caveat, or question.
Davies et al. (1980) conducted an observational in Cardiopulmonary bypass during cardiac surgery (aortocoronary artery grafting or valve replacement). Cardiopulmonary bypass (aortocoronary artery grafting) vs. Valve replacement was evaluated on Plasma fibrinopeptide A and thromboxane B2 levels, and platelet count. Cardiopulmonary bypass was associated with persistent plasma fibrinopeptide A elevation, plus high thromboxane B2 and rapid platelet drop particularly during aortocoronary grafting.
Synapse has enriched 10 related papers. Consider them for comparative context: